Loading

Genetically Modified Plants: Think Twice before Saying

Review Article | Open Access | Volume 4 | Issue 1

  • 1. Centro de Citricultura Sylvio Moreira - IAC, Brazil
+ Show More - Show Less
Corresponding Authors
Raquel Caserta, Centro de Citricultura Sylvio Moreira - IAC, Rodovia Anhanguera km 158, Sao Paulo, Brazil, Tel: 55-19-3546-1399.
Keywords

•    Transgenic
•    Cisgenic
•    Intragenic
•    Public acceptance
•    Crops

ABBREVIATIONS

GM: Genetically Modified

INTRODUCTION

Historically, the release of genetically modified plants (GMs) for cultivation and commercialization generates divergences of public opinion that guides the elaboration of favorable or unfavorable policies to the subject. Certainly, cultural issues are central to determine the behavior of acceptance or refusal to the presence of GM foods on the market. Clearly there are two market poles when the subject is GM: a more favorable, like the North American, and a more unfavorable, like the European. However, the development and release of GM foods grow not only in developed countries, but in developing countries, where consumer behavior is largely defined by food shortages or reduced purchasing power. Currently, genetically modified plants of first, second and third generation are a reality around the world and the formation of a public opinion on the subject needs to consider different proposals of development of such plants.

GENETICALLY MODIFIED PLANTS OF FIRST, SECOND AND THIRD GENERATION

Genetically modified plants (GM) plants are divided into three groups, depending on the purpose of its generation. GM plants of first generation are those with input traits basically related to increase insect and herbicide resistance. GM plants of second generation present output traits related direct to benefit the consumer, aiming mainly to add value to the final product through nutritional improvement or better storage conservation. GM plants of third generation can be so called “green factories” and be used in the production of novel products, like pharmaceuticals and biofuels in an environmentally sustainable manner [1].

GM plants of first generation are the most widespread cultivated crops and have been commercialized since the mid1990s. GM crops with resistance traits to herbicide and insect attack were used on about 12 percent of the world’s cultivated area by 2015. Among them, soybean is the most cultivated, followed by cotton, maize and canola [2]. Basically, these crops are present in all of the global territory, representing 179.7 million hectares of cultivated area in 2015 [3]. This massive growth of GM crops is directly linked to the economic benefits provided, such as reduction in herbicide application and increasing in yields.

Genes commonly used to confer insect resistance traits are those isolated from the soil bacterium Baccilusturingiensis (Bt) encoding Cry or Vip proteins, used against lepidopteron and coleopteran pests. Herbicide resistance traits are given from genes like bar, pat, gox, EPSPS, also isolated from bacteria [4]. These new traits are responsible for increasing in production and reduction of insecticides in such crops. For example, in India the cultivation of Bt GM cotton, a pest-resistant crop, started in 2002 and since then increasing in yields have been observed reaching $18.3 billion in 2014 in farm income gains [3].

Meanwhile, poisoning due the use of insecticide decreased among Chinese farmers who adopted Bt rice. Results showed a reduction of 50–60% in pesticide spraying in such crops from Wuhan producers and physical examinations showed improved health through the adoption of Bt rice [4,5]. In addition, a reduction of approximately 41% in insecticide use through Bt technology in cotton farms has also been reported over three growing seasons in India, improving producer’s health [6].

Moreover, comparisons between yields of crop varieties with Bt to yields of varieties without Bt showed that Bt in maize and cotton contributed to a reduction in the gap between actual yield and potential yield, from 1996 to 2015 when targeted pests could not be controlled by synthetic chemicals and caused substantial damage to non-GM varieties. In Brazil, the second biggest GM grower, the most cultivated biotech crop is soybean, with 32.2 million hectares in 2015. Both herbicide tolerant and insect resistant cultivars are present. Maize is the second most biotech crop cultivated and is estimated that during the crop period of 1996/97 to the 2012/13, benefits for users of this technology have reached US$24.8 billion [2]. According to recent data, due to GM crops Brazil gained US$2.5 billion for 2014 alone [3].

Lately, cultivation of crops with stacked traits has been increasing, corresponding to almost 33% of the total GM area in 2015 [2]. This increase fits perfectly to the higher potential of such crops. One of them is the delay in the evolution of pest resistance to the inputted trait. Since two or more genes against insect-pests are introduced to a same variety, the speed of generation of resistant insects can be slowed, allowing growers to reduce the refuge area recommended. As an example, recently, two companies received approval for the cultivation of a hybrid corn with eight different genes for herbicide tolerance and insect-protection. This product was created by breeding crosses of previously approved GM events presenting genes like Cry1Fa, Cry34Ab, Cry35Ab, Cry3Bb/RR2, Cry1A.105 and Cry2Ab for pest control, and two genes related to weed control - RR2 and EPSPS. The approval was given by the Environmental Protection Agency (EPA) from United States and allowed growers to reduce the refuge area for this culture from 20 to 5% in the US Corn Belt [7].

In 2013 studies associated a reduction of 18.3% in the environmental impact in areas cultivated with GM and an 8.9% reduction in the use of herbicides and pesticides [8]. This reduction reflects on the survey of non-target insects in GM areas and around. Probably, the biggest worry concerning insect resistant GM crops are related to honey bees, once they represent a species of high economic and environmental importance. Due to its world occurrence, honey bees have been used as surrogate species for studies of non target insect effects of GM crops. Recent results showed that different classes of Cry proteins do not promote changes in their hypo pharyngeal gland, a very important gland for this insect, and are not harmful for adult bees or larvae, in comparison to insecticides commonly used [9-11].

The second-generation of GM plants enclose those products with traits that will benefit final consumers directly, such as improved nutritional qualities. Possibly they will face less market resistance than first generation GM crops due to their direct advantages. The first GM food released for consumption, the tomato Flavr Savr by Calgene company failed the marked due to high production and distribution costs [12]. This fact, however, did not discourage companies from developing new genetically modified foods based on consumer needs. The new wave of GM foods launched have Artic Apples® and Innate® Potatoes as examples of products that focus on benefits to the consumer with traits related to low bruise and non browning, higher resistance to blight and higher nutritional quality. Artic Apples®, developed by Okanagan Specialty Fruits®, present two approved varieties of apples called Artic® Golden and Artic® Granny. These products do not turn brown due to the silencing of four genes from the polyphenol oxidase (PPO) family. Even though consumers and market claim for GM food free of selection genes or sequences unrelated to eukaryotes, the Artic Apples® contain genes of Cauliflower Mosaic Virus and Escherichia coli but its safety was ensured by scientists of Health Canada who also allowed commercialization [13]. On the other hand, Innate® Potatoes developed by J. R. Simplot© have traits conferred by genes exclusively isolated from cultivars of potatoes, providing reduced bruise and black spots, late blight resistance, higher nutritional quality and enhanced cold storage capability [14]. The most recently products approved for consumption that are under spotlight are the pink pineapple from Del Monte Fresh Produce, containing lycopene due to the silencing of the enzyme and Purple Tomato, from Norfolk Plant Science, that produces high levels of anthocyanins, an antioxidant known for its benefits for human health. Studies showed extension of life span of cancersusceptible mice fed with high-anthocyanin tomatoes, suggesting that the accumulation of anthocyanin present in tomatoes was efficient for improving the health of the animals tested [15]. The market success of such products is still to be watched. Older than Artic Apples® and Innate® Potatoes, Golden Rice and Banana 21 projects aim to biofortify staple foods by adding new nutritional traits like pro vitamin A and iron. Although results have demonstrated that the pro vitamin A from Golden Rice is indeed absorbed by human intestine [16], this product is not yet approved for commerce.

The third generation of GM crops is heading towards a new era of technology through the application of synthetic biology to engineer plants with new input and output traits. The use of synthetic biology is beyond additions of transgenes, but aims the direct design of new metabolic pathways, physiological traits, and developmental control strategies, exploiting the potential of generation of plant varieties, or even species, for the production of chemicals and biomaterials, creating a class of plants destined for processing and not for food [17]. The creation of plants with biorefining, bioremediator, biosensors and other purposes with the construction of synthetic signaling pathways, engineering metabolism through compartmentalization, improvement of polysaccharide composition and diversification of secondary metabolism is becoming a reality [18]. It has already been demonstrated that GM plants are capable of remediate persistent organic pollutants like 2,4,6-trinitrotoluene (TNT), hexahydro1,3,5-trinitro-1,3,5-triazine (RDX), trichloroethylene (TCE), and polychlorinated biphenyls (PCBs). Genetically engineered model plants as Arabidopsisthaliana and Nicotianatabacum showed the ability to degrade such chemicals, and other plants like poplar, switch grass and hybrid aspen are being used to the same goal [19]. A recent demonstration that the use of plants as green factories for the synthesis of drugs and vaccines is possible occurred in the last outbreak of Ebola virus when the treatment of some infected patients was authorized even without previous clinical trials. The patients were treated with three monoclonal antibodies obtained by transient expression in Nicotianabenthamiana [20]. The success of such treatment excited continuous studies for development of vaccines against Ebola using different virus targets and immunization purposes [21].

CISGENIC AND INTRAGENIC: A NEW APPROACH ON GM AIMING BETTER ACCEPTANCE

Probably, the popular acceptance of GM first-generation crops has been hampered due to a lack of information and mainly a lack of sense of direct benefits that such products provide to the final consumer. Coupled to the resistance and distrust that all new technology generates, the popularization of GM foods is still a hindrance. Perhaps this scenario tends to be altered by a new concept of GM that aims to produce plants with traits closer to the conventional breeding.

A “cisgenic plant” refers to “a crop plant that has been genetically modified with one or more genes containing intron and flanking regions such as native promoter and terminator regions in a sense orientation) isolated from a crossable donor plant” [22]. Basically, it means that the cisgenic crop is created by the introduction of a native complete copy of the natural gene with all its regulatory elements, maintaining their natural genetic composition. The source of a cisgenic is the same plant species or a sexually compatible species, and different from the traditional breeding, cisgenic crops contain only the desired gene or genes and no other genetic elements [23]. Indeed cisgenesis can overcome a major bottleneck in traditional breeding due to the possibility of monitoring the trait or traits that are being transferred without linkage drag issues that slow down breeding [24]. The other concept, an intragenic crop is a GM where the transformed intragene is obligatory isolated from the same species or a crossable species, but its regulatory elements like promoter and termination regions can be originated from different genes and loci. Due to the possibility of new combinations, intragenes can be considered hybrid genes [25]. Such combinations allow novel gene expression patterns and GM with innovative properties [23].

According to recent studies, cisgenic and intragenic plants are tending to alter consumers point of view about GM foods [26,27]. Although deep studies have demonstrated that long-term feeding with GM foods is safe [28], a large part of the population refuses to accept their commercialization. Due to considering that cisgenic are more natural products, their acceptance is greater among Europeans consumers, once GM foods are seen as “unnatural” [26]. Although better, this acceptance is still low when compared to Indian consumers. Recent studies about commercialization of a GM rice showed that survey respondents were willing to pay for cisgenic or ‘GM’ rice since both or some of them had the “no fungicide” attribute. Among consumers, 73% willingness-to-consume cisgenic rice and 76% answered the same to GM rice. Interestingly, 88% agreed about labeling cisgenic rice as GM, and this seems to be less important for the purchase than price or fungicide usage [27]. These data suggests that the opinion of consumers may have been changing in relation to acquisition of GM foods available in the marketing. Recently, it has been proposing a labelling scheme according to the category in which the product fits: Pest Resistance (PR), Enhanced Nutrition (EN), Environmental Stress Resistance (SR), and Improved Yield (IY). Product labels are asked to contain a “Quick Response” code that after scanned links the consumer to a USDA website with additional information about the GM. Labeling GMs properly will possibly allow consumers to re-evaluate their opinion and increase their knowledge about the theme [29].

FINAL CONSIDERATIONS

The first generation of GM plants brought a very innovative approach that proposed reduction or extinction of the use of pesticides and herbicides, thus generating greater production gains. First-generation plants have genetic characteristics that confer advantages, making their cultivation preferred over unmodified plants. Although benefits brought by GM crops are scientific certified, the cultivation of such plants is still an object of great social refusal. The reasons for such refusal range from fear to criticism to the monopoly of the GM seed market by some companies. Indeed, the absence of perception of direct benefits to the final consumer brought by first-generation GM plants, helped to make the popular refusal even greater. However, secondgeneration of GM plants are increasingly gaining the fresh market consumption with products that bring better nutritional value and are more durable, directly benefiting consumers. Differences in the genetic origins of the sequences introduced in some of these products can contribute to a change of behavior in relation to GM plants. Finally, it is still necessary to get used to an idea of plants produced for processing and not for consumption, as the case of GM plants of third generation. The potential for development of such biofactories is enormous and tends to be increasingly explored.

ACKNOWLEDGEMENTS

This work was supported by research grants from Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq - 40500412013-7 and 150820/2015-1).

REFERENCES

1. Halpin C. Gene stacking in transgenic plants - the challenge for 21st century plant biotechnology. Plant Biotechnol J. 2005; 3: 141-155.

2. James C. 20th Anniversary (1996 to 2015) of the Global Commercialization of Biotech Crops and Biotech Crop Highlights in 2015. ISAAA. 2015.

3. Brookes G, Barfoot P. Global impact of biotech crops: socio-economic and environmental effects 1996-2014. Agbioforum. 2016; 11: 21-38.

4. Wang YM, Zhang GA, Du JP, Liu B, Wang, MC. Influence of transgenic hybrid rice expressing a fused gene derived from cry1Ab and cry1Ac on primary insect pests and rice yield. Crop Prot. 2010; 29: 128-133.

5. Huang J, Hu R, Qiao F, Yin Y, Liu H, Huang Z. Impact of insect-resistant GM rice on pesticide use and farmers’ health in China. Sci China Life Sci. 2015; 58: 466-471.

6. Qaim M. Benefits of genetically modified crops for the poor: household income, nutrition, and health. N Biotechnol. 2010; 27: 552-557.

7. Que Q, Chilton MD, de Fontes CM, He C, Nuccio M, Zhu T, et al. Trait stacking in transgenic crops: challenges and opportunities. GM Crops. 2010; 1: 220-229.

8. Brookes G, Barfoot P. Key environmental impacts of global genetically modified (GM) crop use 1996-2011. GM Crops Food. 2013; 4: 109-119.

9. Wang YY, Li YH, Huang ZY, Chen XP, Romeis J, Dai PL, et al. Toxicological, Biochemical, and Histopathological Analyses Demonstrating That Cry1C and Cry2A Are Not Toxic to Larvae of the Honeybee, Apismellifera. J Agric Food Chem. 2015; 63: 6126-6132.

10. Dai PL, JiaHR, Jack CJ, GengLL, Liu F, HouCS, et al. Bt Cry1Ie Toxin Does Not Impact the Survival and Pollen Consumption of Chinese Honey Bees, Apisceranacerana (Hymenoptera, Apidae). Journal of Economic Entomology. 2016; 1-5.

11. Wang Y, Dai P, Chen X, Romeis J, Shi J, Peng Y et al. Ingestion of Bt rice pollen does not reduce the survival or hypopharyngeal gland development of Apismellifera adults. Environ Toxicol Chem. 2016.

12. Bruening G., Lyons JM. The case of the FLAVR SAVR tomato. California Agriculture. 2000; 54: 6-7.

13. The Benefits of Arctic Apples.

14. Innate® Generation 2 can significantly contribute to more sustainable potato production.

15. Butelli E, Titta L, Giorgio M, Mock HP, Matros A, Peterek S, et al. Enrichment of tomato fruit with health-promoting anthocyanins by expression of select transcription factors. Nature Biotech. 2008; 26: 1301-1308.

16. Tang G, Hu Y, Yin SA, Wang Y, Dallal GE, Grusak MA, et al. β -Carotene in Golden Rice is as good as β -carotene in oil at providing vitamin A to children. Am J ClinNutr. 2012; 96: 658-664.

17. Fesenko E, Edwards R. Plant synthetic biology: a new platform for industrial biotechnology. J Exp Bot. 2014; 65: 1927-1937.

18. Jenkins T, Bovi A, Edwards R. Plants: biofactories for a sustainable future? Philos Trans A Math Phys Eng Sci. 2011; 369: 1826-1839.

19. Rylott EL, Johnston EJ, Bruce NC. Harnessing microbial gene pools to remediate persistent organic pollutants using genetically modified plants-a viable technology? J Exp Bot. 2015; 66: 6519-6533.

20. Olinger GG, Pettitt J, Kim D, Working C, Bohorov O. Delayed treatment of Ebola virus infection with plant-derived monoclonal antibodies provides protection in Rhesus macaques. Proc Natl AcadSci USA. 2012; 109: 18030-18035.

21. Huerta RR, Escalante EM, Alonso DOG, Angulo C, Mendoza SR. Expression of an immunogenic LTB-based chimeric protein targeting Zaire ebolavirus epitopes from GP1 in plant cells. Plant Cell Rep. 2016.

22. Schouten HJ, Krens FA, Jacobsen E. Do cisgenic plants warrant less stringent oversight? Nat Biotechnol. 2006; 24: 753.

23. Espinoza C, Schlechter R, Herrera D, Torres E, Serrano A, Medina C, et al. Cisgenesis and intragenesis: new tools for improving crops. Biol Res. 2013; 46: 323-331.

24. Schouten HJ, Krens FA, Jacobsen E. Cisgenic plants are similar to traditionally bred plants: international regulations for genetically modified organisms should be altered to exempt cisgenesis. EMBO Rep. 2006; 7: 750-753.

25. Rommens CM, Haring MA, Swords K, Davies HV, Belknap WR. The intragenic approach as a new extension to traditional plant breeding. Trends Plant Sci. 2007; 12: 397-403.

26. Myskja BK. The moral difference between intragenic and transgenic modification of plants. J Agric Environ Ethics. 2006; 19: 225-238.

27. Shew AM, Nalley LL, Danforth DM, Dixon BL, Nayga Jr RM, Delwaide AC, et al. Are all GMOs the same? Consumer acceptance of cisgenic rice in India. Plant Biotech J. 2016; 14: 4-7.

28. Snell C, Bernheim A, Berge JB, Kuntz M, Pascal G, Paris A, et al. Assessment of the health impact of GM plant diets in long-term and multigenerational animal feeding trials: A literature review. Food and Chemical Toxicology. 2012; 50: 1134-1148.

29. Kiess ES, Socha AL. Subdividing GMO classifications for food labeling. J Sci Policy & Governance. 2015; 7: 1-3.

Abstract

Since manipulation of DNA sequences was feasible, it has also become feasible to insert such sequences into distinct genomes. The possibility of creating plants with completely new characteristics conferred by one or more genetic sequences is undoubtedly an exciting platform to be explored, and for sure, a point of divergence between to accept or to deny such new variations created. Currently, several products present new traits ranging from insects resistance to vaccine synthesis, and the technique is still a subject of great criticism. Different nomenclatures are adopted for plants that had their genome altered and in this work they will be named genetically modified plants, which encloses plants presenting traits from non-related organisms such as viruses and bacteria, as well as plants belonging to the new concepts of cisgenic and intragenic. These concepts were created due to the possibility of obtaining isolated genes containing their own regulatory elements or genetic combinations between plant regulatory sequences and target genes, allowing the cisgenic technique to be partially considered an improvement on the classical reproduction technique. In this review we will discuss the three generations of GMs developed, as well as the recent questions about the concept of cisgenic and intragenic, and how these new approaches on genome engineered plants can collaborate to overcome public acceptance of an increasing in availability of GM foods for consumers.

Citation

Caserta R, de Souza AA (2017) Genetically Modified Plants: Think Twice before Saying “No”. JSM Genet Genomics 4(1): 1021.

Received : 04 Jan 2017
Accepted : 01 Feb 2017
Published : 03 Feb 2017
Journals
Annals of Otolaryngology and Rhinology
ISSN : 2379-948X
Launched : 2014
JSM Schizophrenia
Launched : 2016
Journal of Nausea
Launched : 2020
JSM Internal Medicine
Launched : 2016
JSM Hepatitis
Launched : 2016
JSM Oro Facial Surgeries
ISSN : 2578-3211
Launched : 2016
Journal of Human Nutrition and Food Science
ISSN : 2333-6706
Launched : 2013
JSM Regenerative Medicine and Bioengineering
ISSN : 2379-0490
Launched : 2013
JSM Spine
ISSN : 2578-3181
Launched : 2016
Archives of Palliative Care
ISSN : 2573-1165
Launched : 2016
JSM Nutritional Disorders
ISSN : 2578-3203
Launched : 2017
Annals of Neurodegenerative Disorders
ISSN : 2476-2032
Launched : 2016
Journal of Fever
ISSN : 2641-7782
Launched : 2017
JSM Bone Marrow Research
ISSN : 2578-3351
Launched : 2016
JSM Mathematics and Statistics
ISSN : 2578-3173
Launched : 2014
Journal of Autoimmunity and Research
ISSN : 2573-1173
Launched : 2014
JSM Arthritis
ISSN : 2475-9155
Launched : 2016
JSM Head and Neck Cancer-Cases and Reviews
ISSN : 2573-1610
Launched : 2016
JSM General Surgery Cases and Images
ISSN : 2573-1564
Launched : 2016
JSM Anatomy and Physiology
ISSN : 2573-1262
Launched : 2016
JSM Dental Surgery
ISSN : 2573-1548
Launched : 2016
Annals of Emergency Surgery
ISSN : 2573-1017
Launched : 2016
Annals of Mens Health and Wellness
ISSN : 2641-7707
Launched : 2017
Journal of Preventive Medicine and Health Care
ISSN : 2576-0084
Launched : 2018
Journal of Chronic Diseases and Management
ISSN : 2573-1300
Launched : 2016
Annals of Vaccines and Immunization
ISSN : 2378-9379
Launched : 2014
JSM Heart Surgery Cases and Images
ISSN : 2578-3157
Launched : 2016
Annals of Reproductive Medicine and Treatment
ISSN : 2573-1092
Launched : 2016
JSM Brain Science
ISSN : 2573-1289
Launched : 2016
JSM Biomarkers
ISSN : 2578-3815
Launched : 2014
JSM Biology
ISSN : 2475-9392
Launched : 2016
Archives of Stem Cell and Research
ISSN : 2578-3580
Launched : 2014
Annals of Clinical and Medical Microbiology
ISSN : 2578-3629
Launched : 2014
JSM Pediatric Surgery
ISSN : 2578-3149
Launched : 2017
Journal of Memory Disorder and Rehabilitation
ISSN : 2578-319X
Launched : 2016
JSM Tropical Medicine and Research
ISSN : 2578-3165
Launched : 2016
JSM Head and Face Medicine
ISSN : 2578-3793
Launched : 2016
JSM Cardiothoracic Surgery
ISSN : 2573-1297
Launched : 2016
JSM Bone and Joint Diseases
ISSN : 2578-3351
Launched : 2017
JSM Bioavailability and Bioequivalence
ISSN : 2641-7812
Launched : 2017
JSM Atherosclerosis
ISSN : 2573-1270
Launched : 2016
Journal of Genitourinary Disorders
ISSN : 2641-7790
Launched : 2017
Journal of Fractures and Sprains
ISSN : 2578-3831
Launched : 2016
Journal of Autism and Epilepsy
ISSN : 2641-7774
Launched : 2016
Annals of Marine Biology and Research
ISSN : 2573-105X
Launched : 2014
JSM Health Education & Primary Health Care
ISSN : 2578-3777
Launched : 2016
JSM Communication Disorders
ISSN : 2578-3807
Launched : 2016
Annals of Musculoskeletal Disorders
ISSN : 2578-3599
Launched : 2016
Annals of Virology and Research
ISSN : 2573-1122
Launched : 2014
JSM Renal Medicine
ISSN : 2573-1637
Launched : 2016
Journal of Muscle Health
ISSN : 2578-3823
Launched : 2016
JSM Genetics and Genomics
ISSN : 2334-1823
Launched : 2013
JSM Anxiety and Depression
ISSN : 2475-9139
Launched : 2016
Clinical Journal of Heart Diseases
ISSN : 2641-7766
Launched : 2016
Annals of Medicinal Chemistry and Research
ISSN : 2378-9336
Launched : 2014
JSM Pain and Management
ISSN : 2578-3378
Launched : 2016
JSM Women's Health
ISSN : 2578-3696
Launched : 2016
Clinical Research in HIV or AIDS
ISSN : 2374-0094
Launched : 2013
Journal of Endocrinology, Diabetes and Obesity
ISSN : 2333-6692
Launched : 2013
Journal of Substance Abuse and Alcoholism
ISSN : 2373-9363
Launched : 2013
JSM Neurosurgery and Spine
ISSN : 2373-9479
Launched : 2013
Journal of Liver and Clinical Research
ISSN : 2379-0830
Launched : 2014
Journal of Drug Design and Research
ISSN : 2379-089X
Launched : 2014
JSM Clinical Oncology and Research
ISSN : 2373-938X
Launched : 2013
JSM Bioinformatics, Genomics and Proteomics
ISSN : 2576-1102
Launched : 2014
JSM Chemistry
ISSN : 2334-1831
Launched : 2013
Journal of Trauma and Care
ISSN : 2573-1246
Launched : 2014
JSM Surgical Oncology and Research
ISSN : 2578-3688
Launched : 2016
Annals of Food Processing and Preservation
ISSN : 2573-1033
Launched : 2016
Journal of Radiology and Radiation Therapy
ISSN : 2333-7095
Launched : 2013
JSM Physical Medicine and Rehabilitation
ISSN : 2578-3572
Launched : 2016
Annals of Clinical Pathology
ISSN : 2373-9282
Launched : 2013
Annals of Cardiovascular Diseases
ISSN : 2641-7731
Launched : 2016
Journal of Behavior
ISSN : 2576-0076
Launched : 2016
Annals of Clinical and Experimental Metabolism
ISSN : 2572-2492
Launched : 2016
Clinical Research in Infectious Diseases
ISSN : 2379-0636
Launched : 2013
JSM Microbiology
ISSN : 2333-6455
Launched : 2013
Journal of Urology and Research
ISSN : 2379-951X
Launched : 2014
Journal of Family Medicine and Community Health
ISSN : 2379-0547
Launched : 2013
Annals of Pregnancy and Care
ISSN : 2578-336X
Launched : 2017
JSM Cell and Developmental Biology
ISSN : 2379-061X
Launched : 2013
Annals of Aquaculture and Research
ISSN : 2379-0881
Launched : 2014
Clinical Research in Pulmonology
ISSN : 2333-6625
Launched : 2013
Journal of Immunology and Clinical Research
ISSN : 2333-6714
Launched : 2013
Annals of Forensic Research and Analysis
ISSN : 2378-9476
Launched : 2014
JSM Biochemistry and Molecular Biology
ISSN : 2333-7109
Launched : 2013
Annals of Breast Cancer Research
ISSN : 2641-7685
Launched : 2016
Annals of Gerontology and Geriatric Research
ISSN : 2378-9409
Launched : 2014
Journal of Sleep Medicine and Disorders
ISSN : 2379-0822
Launched : 2014
JSM Burns and Trauma
ISSN : 2475-9406
Launched : 2016
Chemical Engineering and Process Techniques
ISSN : 2333-6633
Launched : 2013
Annals of Clinical Cytology and Pathology
ISSN : 2475-9430
Launched : 2014
JSM Allergy and Asthma
ISSN : 2573-1254
Launched : 2016
Journal of Neurological Disorders and Stroke
ISSN : 2334-2307
Launched : 2013
Annals of Sports Medicine and Research
ISSN : 2379-0571
Launched : 2014
JSM Sexual Medicine
ISSN : 2578-3718
Launched : 2016
Annals of Vascular Medicine and Research
ISSN : 2378-9344
Launched : 2014
JSM Biotechnology and Biomedical Engineering
ISSN : 2333-7117
Launched : 2013
Journal of Hematology and Transfusion
ISSN : 2333-6684
Launched : 2013
JSM Environmental Science and Ecology
ISSN : 2333-7141
Launched : 2013
Journal of Cardiology and Clinical Research
ISSN : 2333-6676
Launched : 2013
JSM Nanotechnology and Nanomedicine
ISSN : 2334-1815
Launched : 2013
Journal of Ear, Nose and Throat Disorders
ISSN : 2475-9473
Launched : 2016
JSM Ophthalmology
ISSN : 2333-6447
Launched : 2013
Journal of Pharmacology and Clinical Toxicology
ISSN : 2333-7079
Launched : 2013
Annals of Psychiatry and Mental Health
ISSN : 2374-0124
Launched : 2013
Medical Journal of Obstetrics and Gynecology
ISSN : 2333-6439
Launched : 2013
Annals of Pediatrics and Child Health
ISSN : 2373-9312
Launched : 2013
JSM Clinical Pharmaceutics
ISSN : 2379-9498
Launched : 2014
JSM Foot and Ankle
ISSN : 2475-9112
Launched : 2016
JSM Alzheimer's Disease and Related Dementia
ISSN : 2378-9565
Launched : 2014
Journal of Addiction Medicine and Therapy
ISSN : 2333-665X
Launched : 2013
Journal of Veterinary Medicine and Research
ISSN : 2378-931X
Launched : 2013
Annals of Public Health and Research
ISSN : 2378-9328
Launched : 2014
Annals of Orthopedics and Rheumatology
ISSN : 2373-9290
Launched : 2013
Journal of Clinical Nephrology and Research
ISSN : 2379-0652
Launched : 2014
Annals of Community Medicine and Practice
ISSN : 2475-9465
Launched : 2014
Annals of Biometrics and Biostatistics
ISSN : 2374-0116
Launched : 2013
JSM Clinical Case Reports
ISSN : 2373-9819
Launched : 2013
Journal of Cancer Biology and Research
ISSN : 2373-9436
Launched : 2013
Journal of Surgery and Transplantation Science
ISSN : 2379-0911
Launched : 2013
Journal of Dermatology and Clinical Research
ISSN : 2373-9371
Launched : 2013
JSM Gastroenterology and Hepatology
ISSN : 2373-9487
Launched : 2013
Annals of Nursing and Practice
ISSN : 2379-9501
Launched : 2014
JSM Dentistry
ISSN : 2333-7133
Launched : 2013
Author Information X